Dr. Wang has over 25 years of finance and investing experience. He was a Partner of Goldman Sachs where he held many leadership positions during his 18-year tenure at the firm. He joined Goldman Sachs in 1996 and was named Managing Director and Head of U.S. Convertibles Trading in 2002. In 2006 Dr. Wang was named a Partner and Co-Head of U.S. Stock Trading, Stock Options Trading, Convertibles Trading, Risk Arbitrage, and Franchise Risk Management. In 2009 he became Global Co-COO of One Delta Trading, and in 2012 became the unit's Global Co-Head as well as Co-Head of Equities Trading for the Americas.

Dr. Wang is a founding partner of Puissance Capital Management, primarily focusing on investing in innovative healthcare companies in the United States and China. He serves on the boards of Bellerophon Therapeutics, a NASDAQ listed company and Angel Pharmaceuticals, a privately held innovative biotech company in China he co-founded. He also serves as an independent director on the Audit Committee of Fiduciary Trust Company, a Division of Franklin Templeton. He is a founder of Angel Pond Capital LLC, a broker/dealer that provides advisory services in the life science sector. Dr. Wang holds a Ph.D in Physics from the University of Minnesota, an MBA from the University of Texas, Austin, and a B.S. from Fudan University, Shanghai, China. He is a trustee of the Dunhuang Foundation, and a member of Committee of 100, an organization of distinguished Chinese Americans with a mission to improve US-China relations.

Dr. Wang is the Chairman of our Board and a member of the Audit Committee.

Mr. Xie has over 22 years of experience in founding, investing, building and operating businesses in the technology sector. Mr. Xie is a co-founder of China e-commerce company Alibaba Group and served in a variety of leadership roles within Alibaba from its founding in 1999 until his retirement in 2015. Mr. Xie was instrumental in many of the investment decisions driving Alibaba's growth and expansion internally and externally. Some externally sourced investments include an investment in Meituan in 2011 and an investment in Kuaidi Dache in 2013.

Mr. Xie retired from Alibaba in 2015 to focus on early- and middle-stage venture investments. He is the founder of Hangzhou Hupan Shannan Capital Management Co., Ltd., a venture capital fund, where he currently serves as executive director. Mr. Xie holds a B.S. in Engineering from Shenyang University of Technology, Shenyang, China, and an MBA from China Europe International Business School, Shanghai, China.

Mr. Hanchen "Axel" Jin is our Chief Financial Officer. Since 2017, Mr. Jin has served as Chief Financial Officer for Puissance Capital Management. He held positions as an asset management analyst at CSOP Asset Management in 2016, an investment analyst at Minmetals Securities in 2015, and a financial analyst at China Merchants Bank in 2014. Mr. Jin graduated from Indiana University in 2014 and the Gabelli School of Business at Fordham University in 2016.